Autologous mesenchymal stem cell therapy - EHL BioAlternative Names: ADSTEM injection
Latest Information Update: 22 Sep 2016
At a glance
- Originator EHL Bio
- Class Stem cell therapies
- Mechanism of Action Cell replacements; Stem cell stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Atopic dermatitis
Most Recent Events
- 01 Jul 2016 Phase-I clinical trials in Atopic dermatitis in South Korea (IV)